Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Hikma Triumphs As Vascepa Induced-Infringement Case Dismissed
Amarin Had Pursued Firm Over Skinny-Label Generic Icosapent Ethyl Capsules
Jan 10 2022
•
By
David Wallace
The Delaware district court dismissed the complaint against Hikma • Source: Alamy
More from Legal & IP
More from Generics Bulletin